Brain Banking for Research into Neurodegenerative Disorders and Ageing

  • Claire E. Shepherd
  • Holly Alvendia
  • Glenda M. HallidayEmail author


Advances in cellular and molecular biology underpin most current therapeutic advances in medicine. Such advances for neurological and neurodegenerative diseases are hindered by the lack of similar specimens. It is becoming increasingly evident that greater access to human brain tissue is necessary to understand both the cellular biology of these diseases and their variation. Research in these areas is vital to the development of viable therapeutic options for these currently untreatable diseases. The development and coordination of human brain specimen collection through brain banks is evolving. This perspective article from the Sydney Brain Bank reviews data concerning the best ways to collect and store material for different research purposes.


Brain banking Brain donation Neurodegenerative diseases Human brain tissue processing 



We wish to thank the employees of the Sydney Brain Bank, and the institutional funding for the facility from the University of New South Wales and Neuroscience Research Australia.

Conflict of interest

The authors direct and manage the Sydney Brain Bank.


  1. 1.
    Kretzschmar H. Brain banking: opportunities, challenges and meaning for the future. Nat Rev Neurosci 2009, 10: 70–78.CrossRefGoogle Scholar
  2. 2.
    Royal College of Pathologists of Australasia Autopsy Working Group P. The decline of the hospital autopsy: a safety and quality issue for healthcare in Australia. Med J Aust 2004, 180: 281–285.Google Scholar
  3. 3.
    Vonsattel JP, Del Amaya MP, Keller CE. Twenty-first century brain banking. Processing brains for research: the Columbia University methods. Acta Neuropathol 2008, 115: 509–532.Google Scholar
  4. 4.
    Klioueva NM, Rademaker MC, Dexter DT, Al-Sarraj S, Seilhean D, Streichenberger N, et al. BrainNet Europe’s Code of Conduct for brain banking. J Neural Transm (Vienna) 2015, 122: 937–940.CrossRefGoogle Scholar
  5. 5.
    The Lancet Neurology. Brain banking: more effective strategies needed. Lancet Neurol 2013, 12: 1035.CrossRefGoogle Scholar
  6. 6.
    Bell JE, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Budka H, et al. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol 2008, 115: 497–507.CrossRefGoogle Scholar
  7. 7.
    Palmer-Aronsten B, Sheedy D, McCrossin T, Kril J. An international survey of brain banking operation and characterization practices. Biopreserv Biobank 2016, 14: 464–469.CrossRefGoogle Scholar
  8. 8.
    Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011, 134: 2456–2477.CrossRefGoogle Scholar
  9. 9.
    Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The stanley foundation brain collection and neuropathology consortium. Schizophr Res 2000, 44: 151–155.CrossRefGoogle Scholar
  10. 10.
    Nakamura K, Mori F, Tanji K, Miki Y, Toyoshima Y, Kakita A, et al. α-Synuclein pathology in the cranial and spinal nerves in Lewy body disease. Neuropathology 2016, 36: 262–269.CrossRefGoogle Scholar
  11. 11.
    Klos KJ, Ahlskog JE, Josephs KA, Apaydin H, Parisi JE, Boeve BF, et al. Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology 2006, 66: 1100–1102.CrossRefGoogle Scholar
  12. 12.
    Vonsattel JP, Aizawa H, Ge P, DiFiglia M, McKee AC, MacDonald M, et al. An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 1995, 54: 42–56.CrossRefGoogle Scholar
  13. 13.
    Ramirez EPC, Keller CE, Vonsattel JP. The New York Brain Bank of Columbia University: practical highlights of 35 years of experience. Handb Clin Neurol 2018, 150: 105–118.CrossRefGoogle Scholar
  14. 14.
    Ervin JF, Heinzen EL, Cronin KD, Goldstein D, Szymanski MH, Burke JR, et al. Postmortem delay has minimal effect on brain RNA integrity. J Neuropathol Exp Neurol 2007, 66: 1093–1099.CrossRefGoogle Scholar
  15. 15.
    Robinson AC, Palmer L, Love S, Hamard M, Esiri M, Ansorge O, et al. Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK. Acta Neuropathol 2016, 132: 753–755.CrossRefGoogle Scholar
  16. 16.
    Schmitt A, Bauer M, Heinsen H, Feiden W, Consortium of Brainnet Europe, II, Falkai P, et al. How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II. J Neural Transm (Vienna) 2007, 114: 527–537.Google Scholar
  17. 17.
    Nolan M, Troakes C, King A, Bodi I, Al-Sarraj S. Control tissue in brain banking: the importance of thorough neuropathological assessment. J Neural Transm (Vienna) 2015, 122: 949–956.CrossRefGoogle Scholar
  18. 18.
    Tan RH, Yang Y, Halliday GM. Multiple neuronal pathologies are common in young patients with pathologically proven Frontotemporal lobar degeneration. Neuropathol Appl Neurobiol 2017. CrossRefPubMedGoogle Scholar
  19. 19.
    Hulette CM. Brain banking in the United States. J Neuropathol Exp Neurol 2003, 62: 715–722.CrossRefGoogle Scholar
  20. 20.
    Watson PH, Nussbeck SY, Carter C, O’Donoghue S, Cheah S, Matzke LA, et al. A framework for biobank sustainability. Biopreserv Biobank 2014, 12: 60–68.CrossRefGoogle Scholar

Copyright information

© Shanghai Institutes for Biological Sciences, CAS 2019

Authors and Affiliations

  1. 1.Neuroscience Research Australia and the University of New South WalesSydneyAustralia
  2. 2.New York UniversityNew YorkUSA
  3. 3.Brain and Mind Centre, Sydney Medical SchoolUniversity of SydneySydneyAustralia

Personalised recommendations